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Abstract: The winemaking process produces a huge number of pomaces that generally are used
for energy purposes. Further valuable applications such as health-promoting properties are still
under investigation. The seeds of the white berries of Mantonico and Pecorello cv. were extracted
in a Soxhlet apparatus, using n-hexane and chloroform as solvents. Extracts were characterized by
NMR and GC-MS analyses. They were assayed in vitro as wound healing and anti-inflammatory
agents in HaCaT and RAW 264.7 cell lines, respectively. n-hexane Mantonico extract resulted in the
most interesting wound healing sample, while n-hexane Pecorello, containing a good number of
carotenoids, resulted in a good anti-inflammatory candidate. These preliminary findings underlined
the benefit of grape seed extracts valorization due to their health-promoting properties.
Keywords: Soxhlet; grape seeds; anti-inflammatory; wound healing; lipophilic fraction; carotenoids;
HaCaT cell line; RAW 264.7 cell line; NMR; GC-MS
1. Introduction
The recycling of by-products, especially those from plant-based materials, offers important
advantages such as their ecologically friendly nature, low cost, availability, reduction of its storage,
and elimination of the dismissal costs. Wine pomace (WP) consists of the solids remaining
after the fermentation of grapes (Vitis vinifera L.). It includes solid grape parts such as skin,
traces of pulp, and seeds with residues of stalk. WP revalorization is generally exploited to obtain
antioxidants-enriched extracts, which could be combined with other ingredients in functional food
matrixes [1–3]. Moreover, grape seed (GS) oil is an excellent cosmetic ingredient for controlling skin
moisture, being easily absorbed by the skin [4]. Nowadays, several pharmaceutical preparations,
containing GS-derived products, are available [5] and used for their health-promoting properties [6].
For instance, GS extracts (aqueous or alcoholic) have shown high antioxidant potential, leading to
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anti-atherosclerotic and anti-inflammatory effects [7], protection against cellular oxidative damage,
modulation of antioxidant enzyme expression and protection against some types of cancer, in both
human and animal models [8]. Among wine by-products, GSs are the most abundant and represent
the portion of the fruit containing the higher concentration of bioactive molecules [9]. Furthermore,
seeds showed the highest antioxidant activity, followed by skin and pulp. Indeed, GS have a great
biological potential, which could be exploited by extracting bioactive compounds before addressing
it as biomass for energy purposes. In this context, GSs can be considered a resource instead of
waste [10]. In particular, the oils that can be extracted from seeds of different grape varieties own
high value, as they contain large fractions of polyunsaturated fatty acids and they can be marketed
at relatively high prices [11]. GS oil contains a large number of phenolic compounds, including
flavonoids, carotenoids, phenolic acids, tannins, and stilbenes. This composition is tightly related to
grapevine variety, environmental factors, and maturation degree of the grapes [8]. The healing of
skin wounds and particularly chronic wounds is still a clinical emergency. Indeed, despite the many
therapeutic tools that are available so far, none seems to be completely effective and safe, with the
incomplete healing process leading to infection development, higher inflammatory state, reactive
oxygen species (ROS) production and pain [12]. The topical application of a hydro-alcoholic GS extract
has been reported to promote wound healing in rabbits [13]. Moreover, a proanthocyanidin-enriched
GS extract, containing 5000 ppm resveratrol, was able to accelerate wound contraction and closure
in mice, by upregulating VEGF expression in keratinocytes [14]. Other studies showed that GS oil
could be an effective wound healing agent, thanks to the synergy between the antibacterial and
antioxidant effect at the wound site. Furthermore, the topical application of a cream containing 2%
GS extract led to the complete wounds closure in 8 days, which was faster than the placebo group
(i.e., 14 days) [15]. Regarding the topical application, it was also shown that a GS extract embedded in
hydrogel formulations was able to trigger wound healing, due to a synergistic action among hydrogel
and bioactive components of the extract [16]. Interestingly, a GS oil, containing high amount of linoleic
and oleic acid, was successfully used to increase the wound closure rate in rats [17]. The principal
components of GS oil are generally fatty acids, well known to be useful remedies in wound healing
disorders, especially associated to type-2 diabetes, employed alone or linked to polyphenols and
other natural compounds [15–18]. The scope of this experimental work was to exploit the in vitro
wound healing properties of four different fatty acid-enriched GS extracts, i.e., chloroform Mantonico
(CM), chloroform Pecorello (CP), n-hexane Mantonico (HM), and n-hexane Pecorello (HP), obtained
by Soxhlet extraction, derived from two autochthonous Calabrian cultivars, which, by far, have been
only investigated for their vasoactive properties [5]. Furthermore, the anti-inflammatory potential,
evaluated as the ability to attenuate the production of nitric oxide (NO) in RAW 264.7 macrophages cell
line, was investigated for each extract, in order to assess if the extracts could have different therapeutic
applications, that will be further analysed.
2. Results and Discussion
2.1. Extraction and Chemical Characterization of the Extracts
The procedure used to obtain the samples was a Soxhlet extraction with lipophilic solvents, able to
extract apolar substances, preferentially. In particular, the extraction was conducted with chloroform
and n-hexane because of their suitable affinity with fatty acids. Overall, the extracts were characterized
through NMR and GC-MS analyses. The NMR technique was used to quantify the detected compounds
in the extracts. In particular, the principal components recovered were fatty acids, including oleic
and linoleic acids, present in good amounts in all the extracts. Appreciable amounts of high-quality
products, oleanoic acid and carotenoids have been detected in all the samples, with HM containing the
highest amount of fatty acids, glycerols, and phenolic compounds. HP contained the higher content of
carotenoids, compared to the others (Table 1, Figure 1). All the NMR spectra are reported in Supporting
Information (Figures S1–S8, Table S1).
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Table 1. 1H-NMR quantitative analyses of extracts.
Compounds 1 Assignment 2 Multiplicity 3 δ H (ppm)
Amount (µmol/g) 4
CM CP HM HP
Stearic acid CH2-CO2- t 2.30 24.71 14.21 269.58 69.87
Oleic acid CH2-CH=CH m 2.03 33.93 18.47 375.04 97.44
Linoleic acid =CH-CH2-CH= t 2.76 92.71 64.04 1177.66 277.85
Oleanoic acid CH-3 m 3.60 3.24 1.79 17.79 4.21
Glycerol CH2 dd 3.65–3.55 48.57 31.31 587.87 142.58
Carotenoids CH-11,11′ m 6.68 0.77 0.54 2.69 7.19
Total Phenols Aromatic moieties m 6.8–7.0 3.11 1.46 3.02 0.00
Aldehydes CHO brs 9.76 0.35 0.09 2.90 0.87
1 Metabolites identified in the 1H NMR spectrum of the (C) and (H) extracts of seeds. 2 chosen for metabolite
quantification. 3 s: singlet, brs: broad singlet, t: triplet, dd: doublet of doublets, m: multiplet. 4 The SD associated to
the measure is 5% of the value.
Pharmaceuticals 2020, 13, x FOR PEER REVIEW 3 of 12 
 
Table 1. 1H-NMR quantitative analyses of extracts. 
Compounds 1 Assignment 2 Multiplicity 3 δ H (ppm) 
Amount (µmol/g) 4 
CM CP HM HP 
Stearic acid CH2-CO2- t 2.30 24.71 14.21 269.58 69.87 
Oleic acid  CH2-CH=CH m 2.03 33.93 18.47 375.04 97.44 
Linoleic acid  =CH-CH2-CH= t 2.76 92.71 64.04 1177.66 277.85 
leanoic acid  CH-3 m 3.60 3.24 1.79 17.79 4.21 
Glycerol  CH2 dd 3.65–3.55 48.57 31.31 587.87 142.58 
Carotenoids  CH-11,11′ m 6.68 0.77 0.54 2.69 7.19 
T al Phenols  Aromatic moieties m 6.8–7.0 3.11 1. 6 3.02 0.00 
Aldehydes  CHO brs 9.76 0.35 0.09 2.90 0.87 
1 Metabolites identified in the 1H NMR spectrum of the (C) and (H) extracts of seeds. 2 chosen for 
metabolite quantification. 3 s: singlet, brs: broad singlet, t: triplet, dd: doublet of doublets, m: multiplet. 
4 The SD as ociated to the measure is 5% of the value. 
 
Figure 1. Representative 1H monodimensional (A) and 1H-1H TOCSY (B) NMR spectra of HP 
extract. 
The composition of the extracts was further examined via qualitative GC-MS analysis (Table 2), 
affording the volatile compounds of the samples. Different fatty acids, including saturated and non-
saturated fatty acids, were recovered, including also different amines and aldehydes. All the GS-MS 
spectra are reported in Supporting Information (Figures S9–S12; Tables S2–S5). 
Table 2. GC-MS analysis of the extracts. 
 CM CP HM HP 
Compounds % of compound  
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester - - 2.19 0.53 
2,4 Decadienal 13.43 - 9.76 10.37 
2,4-Decadienal, (E,E)- 9.17 15.59 - 5.83 
2-Decenal, (E)-  - 5.01 - 1.48 
2-Decenal, (Z)- - - 4.02 - 
E-2-dodecenal - - - 0.93 
Eicosane - - 5.57 0.48 
2-Heptenal, (E)- 12.45 12.59 12.45 4.53 
13-Hexacosyne - - 2.41 - 
Hexadecanoic acid 5.10 5.58 3.96 8.03 
Hexadecanoic acid, ethyl ester - - - 0.89 
Hexane, 1,1-diethoxy- - 1.58 5.27 1.18 
Linoleic acid, butyl ester 2.91 - - - 
Figure 1. Representative 1H monodimensional (A) and 1H-1H TOCSY (B) NMR spectra of HP extract.
The composition of the extracts was further examined via qualitative GC-MS analysis (Table 2),
affording the volatile compounds of the samples. Different fatty acids, including saturated and
non-saturated fatty acids, were recovered, including also different amines and aldehydes. All the
GS-MS spectra are reported in Supporting Information (Figures S9–S12; Tables S2–S5).
Table 2. GC-MS analysis of the extracts.
CM CP HM HP
Compounds % of compound
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester - - 2.19 0.53
2,4 Decadienal 13.43 - 9.76 10.37
2,4-Decadienal, (E,E)- 9.17 15.59 - 5.83
2-Decenal, (E)- - 5.01 - 1.48
2-Decenal, (Z)- - - 4.02 -
E-2-dodecenal - - - 0.93
Eicosane - - 5.57 0.48
2-Heptenal, (E)- 12.45 12.59 12.45 4.53
13-Hexacosyne - - 2.41 -
Hexadecanoic acid 5.10 5.58 3.96 8.03
Hexadecanoic cid, ethyl ester - - - 0.89
Hexane, 1,1-diethoxy- - 1.58 5.27 1.18
Linoleic acid, butyl ester 2.91 - - -
Linoleic acid, ethyl ester - 9.87 - -
9,12-Octadecadienoic acid, ethyl ester - - - 12.30
9,12-Octadecadienoic acid (Z,Z)- 42.50 31.19 6.59 49.60
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Table 2. Cont.
CM CP HM HP
Compounds % of compound
Octadecane - - 2.53 -
Octadecanoic acid 11.22 - 7.58 -
9-Octadecenoic acid (Z)- - - 14.09 -
1-Octanamine, N-methyl-N-octyl- - - 3.31 -
1-Octanamine, N,N-dioctyl- - - 2.13 -
2 Octenal - 1.58 - -
2-Octenal, (E)- - - - 0.59
1-Octen, 3-ol - 2.09 - -
Phthalic acid, isobutyl nonyl ester - 0.51 - -
Tetradecanoic acid, ethyl ester - 0.98 - -
-: not detected.
2.2. Scratch Wound Healing Assay in HaCaT Cell Line
Table 3 shows the wound healing rate of untreated and TGF-β-stimulated HaCaT cells. The ability
of the in vitro model to reproduce wound healing was confirmed by the fact that untreated cells
were able to migrate toward the wound area after both 6 and 24 h. Moreover, TGF-β, used as a
positive control, increased the wound healing rate after 24 h by approximately 20%, compared to the
untreated control.
Table 3. Wound healing percentage of untreated and TGF-β-stimulated HaCaT cells.
Treatment 6 h 24 h
Ctrl 19.39 ± 3.18 36.64 ± 3.86
TGF-β a 17.06 ± 1.72 43.87 ± 2.58
a 4 ng/mL.
The concentrations of the sample for the biological assays were chosen on the basis of cell viability
experiments (Figure S13, Supporting information). CM, CP, and HP did not stimulate the wound
healing rate, compared to the untreated control. Notably, HM was able to increase the keratinocytes
wound healing in a concentration-dependent manner after 6 and 24 h (Figure 2).Pharmaceuticals 2020, 13, x FOR PEER REVIEW 5 of 12 
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Figure 2. Scratch wound healing as ay. The as ay was performed 6 (left) and 24 (right) hours after
treating HaCaT cells with increasing concentrations (0.1 to 10 µg/mL) of different extract (as indica ed)
or DMSO (Ctrl). Data are expressed as mean ± SD of three independent experiments and no malized to
the Ctrl value * p < 0.05 vs. control; ** p < 0 01 vs. control; *** p < 0.001 vs. control by one-way NOVA.
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The maximum effect was obtained with the concentration of 10 µg/mL after 24 h (+50% compared
to the untreated control). Representative images showing the effect of HM 10 µg/mL on HaCaT cells
wound healing are reported in Figure 3. These results are consistent with the chemical composition of
the extracts, with HM containing the higher amount of fatty acids, compared to the others. Indeed,
fatty acids have been reported to induce beneficial effect on different phases of the wound healing
process [18–20]. Moreover, we recently reported that hybridization of quercetin and oleic acid led to
increased keratinocytes wound healing by targeting the FFA1/GPR40. Compared to quercetin alone, the
hybrid demonstrated a better biological effect, highlighting the importance of fatty acid moiety [21,22].
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Figure 3. Representative images of the scratch wound healing assay. The images show the effect of Ctrl
at t0 (A), 6 (B) and 24 h (C) and HM 10 µg/mL at t0 (D), 6 (E) and 24 h (F).
The wound healing effect of HM seems to be related to th stimulation of kerati ocytes migration,
as no increase of cell proliferation were observed in the SRB assay after 6, 24, 48, and 72 h (Figure 4).
The migration-specific effect could be b neficial, as a normal keratinocytes proliferation can alterate the
epidermal mesenchymal interactions, leading to delayed reepithelialzation or hyp rtrophic sc rs [23].
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HP extract, while no significant effect was observed with the other extracts, at the tested 
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Figure 4. Cell proliferation assay. HaCaT cells were treated with increasing concentrations (0.1 to
10 µg/mL) of different extract (as indicated) or DMSO (Ctrl). The SRB absorbance at 540 nm was
recorded 6, 24, 48, and 72 h after treatment. Data are expressed as mean ± SD of three independent
experiments and normalized to the Ctrl value. One-way ANOVA was used for determining the
statistical differences between groups.
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In the attempt to better understand the mechanism of action of HM, we dosed the intracellular
levels of TGF-β and the release of MMP-9. However, as reported in Figure 5, no significant difference
was observed between the HM-treated cells and the untreated control, even if a tendency to increase
TGF-β could be noted with the higher concentration of HM.
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24 h. TGF-β levels and MP-9 r lease were a se sed y - titi sa ic ELISA. Data re
expressed as mean ± SD of three independ t xperiments and normalized to the C rl value. One-way
ANOV was used for determining the statistical differences b tw en groups.
2.3. Inhibition of Nitric Oxide Production in Lipopolysaccharide (LPS)-Stimulated RAW 264.7 Macrophages
The anti-inflammatory potential of the extracts was assessed by monitoring their ability to inhibit
nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages,
which are widely used for preliminary in vitro studies of anti-inflammatory candidates. Indeed,
through the TLR4 receptor, the bacterial lipopolysaccharide (LPS) is able to activate the inflammation.
The successive activation of the transcription factor Nuclear Factor Kappa B (NF-κB) stimulates the
expression of inflammatory related enzymes [24]. Among these, the inducible nitroxide synthase (iNOS)
is responsible for the NO synthesis following the inflammatory stimulus. Our results, shown in Figure 6,
revealed a marked dose-dependent anti-inflammatory activity for the HP extract, while no significant
effect was observed with the other extracts, at the tested concentrations. Moreover, the analysis of
cell viability, by using MTT assay, demonstrated the absence of toxic effects mediated by the extracts,
confirming that the NO reduction observed for HP extract is actually the result of interactions with
the inflammatory pathway and not the reflection of a reduced cell viability. By weaving the results
obtained with the composition of the different extracts, it emerges that the highest carotenoid content
may underlie the HP anti-inflammatory potential. Indeed, with the same extraction method, Pecorello
grapevine cultivar proved to be richer in carotenoids than Mantonico cultivar. Carotenoids are natural
products with known antioxidant and anti-inflammatory power [25,26], mediated both by the activation
of the transcription factor Nrf2, responsible for the cellular anti-inflammatory response, and by the
inactivation of the NF-κB, which mediates pro-inflammatory effects instead. The inhibition of NO
production by HP, observed in our experimental conditions, could therefore be the result of inhibitory
effects of carotenoids on the NF-κB pathway.
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assay, in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells treated with increasing doses (0.1 to
10 µg/mL) of different extract (as indicated) or DMSO (Ctrl). Data are expressed as percentage of
nitrite production versus control (DMSO-treated cells). (B) Viability assessment, by MTT assay, of cells
treated as indicated above. Values represent mean ± SD of three independent experiments. * p < 0.05;
*** p < 0.001; ns = not significant.
3. Materials and Methods
3.1. Plant Material
Pomaces derived from Mantonico (M) and Pecorello (M) white grapes were provided from Le
Moire srl ( tr Strivillati Motta Santa Lucia, Catanzar , Italy) of Dr. Paolo Chirillo (Latitu : 39◦05′28”
N–Longitude: 16◦17′35” E–Altitude: 527 m) and harvested in September and October 2018. All the
samples were stored at −18 ◦C ntil use.
3.2. Chemicals
All the solvents used, including n-hexane, chloroform and methanol were of ultrapure grade,
used wi out further purification and acquir d from Levanchimica s.r.l. (Bari, Italy). Chloroform-d
(CDCl3) and 3-(Trimethyls lyl)propioni -2,2,3,3-d4 acid sodium salt (TSP) were bought fr m Merck
(Darmstadt, Germany).
3.3. Extraction Procedure
Seeds were separated from the skins and milled to obtain a fine powder using a blender type
A11 basic. The powder was then freeze-dried and stored at −18 ◦C until use. Two Soxhlet extractions
were performed starting from 15 g of powders employing 500 mL of n-hexane (H) and chloroform (C),
respectively, for 8 h. The solvent was evaporated at 40 ◦C using a Buchi rotavapor R-II (Postfach 9230
Flawil, Switzerland) to give four different extracts: HM (3.20 g), HP (2.95 g), CM (2.31 g), CP (2.35 g).
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3.4. Gas-Chromatography/Mass Spectrometry (GC/MS) Analysis
The composition of the extracts CM, CP, HM, and HP was determined by GC-MS qualitative
analyses, performed in an Agilent Technologies 6850 Network GC System, using a 5973 Network
Mass Selective Detector, a 7683B Automatic Sampler (Santa Clara, CA, USA), and a capillary column
(HP-5MS 5% Phenyl Methyl Siloxane, length 30 m, i.d. 0.25 mm, film thickness 0.25 µm). All the
lipophilic extracts (~10 mg) were dissolved in 1 mL of n-hexane and peak identification was made
by means of Wiley7n and NIST11 GC libraries. All the reported compounds have more than 80% of
overlap with the references. Relative integrations were made for sake of comparison between the
analysed samples.
3.5. Nuclear Magnetic Resonance (NMR) Analysis
Extracts were analysed with 1H NMR, 1H-1H TOCSY homonuclear bidimensional experiments
in order to establish, when possible, the quantitative amount of substances. Samples (1 mg) were
re-suspended in 600 µL of CDCl3 containing TSP (2 mM) as internal standard. Mono-dimensional 1H
NMR spectra were acquired after 64 scans for each spectrum on a Bruker Avance 400 spectrometer
(Bruker Spectrospin, Karlsruhe, Germany) operating at 9.4 T at 298 K using a 90◦ detection pulse and
acquiring the FIDs in 64 K points, the spectral width was 6009.15 Hz. The solvent signal was suppressed
by means of a presaturation scheme and the relaxation delay was set to 6.55 s in order to achieve a
15 s total acquisition time to avoid relaxation effects. Homonuclear 1H-1H TOCSY experiments were
performed in order to ensure signal assignment. TOCSY experiments were acquired with a spectral
width of 6009.15 Hz in both dimensions, a data matrix of 8 K × 256 points, a mixing time of 110 ms and
relaxation delay of 2 s. Monodimensional 1H spectra were analyzed with 1D- NMR Manager software
ver. 12 (ACD/Labs, Toronto, ON, Canada): FIDs underwent exponential multiplication (LB = 0.09 Hz),
were Fourier transformed, and phase and baseline corrected. Bidimensional spectra were processed
with Bruker Topspin ver. 2.1. The assignment of the resonances was performed by analysing 1H
NMR characteristics and cross-correlated signals in 2D spectra and by comparison with the literature
compilations. Quantification of the identified compounds was performed by comparison of the signal
integral with the reference one, and quantities were expressed in mg of compound normalized for the
aliquot weight expressed in g.
3.6. Cell Cultures and Treatments
Human keratinocytes from adult skin (HaCaT) were cultured in 75 cm2 flasks (Sarstedt,
Milan, Italy) in complete Dulbecco’s Modified Eagle’s medium (DMEM), which was composed
of DMEM (Sigma-Aldrich, Milan, Italy) medium with 10% heat-inactivated fetal bovine serum
(FBS, Sigma-Aldrich) and 1% L-glutamine (Sigma-Aldrich). Murine macrophages RAW 264.7 cell
line was obtained from the American Culture Collection (ATCC, Manassas, VA) and cultured in
DMEM supplemented with 10% FBS, 2 mM L-glutamine and 1% penicillin/streptomycin (Gibco, Life
Technologies, Waltham, MA, USA). All cells were cultured at 37 ◦C in a humidified atmosphere
containing 5% CO2. Number of cell passages was kept under 20 from the reference culture (ATCC) [27].
EDTA-trypsin (Sigma-Aldrich) solution was used for detaching cells from flasks, and cell counting
was performed using a hemocytometer by Trypan Blue staining. Samples were solubilized in dimethyl
sulfoxide (DMSO) and diluted in complete medium in order to reach the final concentrations. DMSO
concentration in each final treatment was maintained below 0.1% and the untreated control was
represented by the same amount of DMSO present in the treatments.
3.7. HaCaT Cell Viability Assay
Cell viability was assessed using the cell counting kit 8 (CCK-8, Sigma-Aldrich) as previously
described [28]. Briefly, 5 × 104 cells/well were seeded into 96-well plates and grown to confluence.
Medium was then replaced with 100 µL of fresh DMEM containing increasing concentrations of
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the samples to the appropriate well. After the incubation time, 10 µL of CCK-8 was added to each
well and incubated for 1 h. Absorbance was measured at 450 nm using a MP96 microplate reader
spectrophotometer (Safas, Monte Carlo, Principality of Monaco). Treatments were performed in
sextuplicate in three independent experiments and cell viability was calculated by normalizing the
absorbance of the test wells to the untreated control.
3.8. HaCaT Scratch Wound Healing Assay
The scratch wound-healing assay was applied by slightly modifying the protocol of Chen (2012)
as previously described [12,21,29]. Briefly, HaCaT cells (5 × 104) were seeded into six-well cell culture
plates and allowed to grow to 70–80% confluence as a monolayer. The monolayer was gently scratched
across the center of the well with a sterile one-mL pipette tip. A second scratch was performed in
a perpendicular way to the first, creating a cross in each well. After scratching, the medium was
removed, and the wells were washed twice in PBS (Sigma-Aldrich) solution. Fresh medium containing
5% v/v of heat-inactivated FBS and treatments was added to each well, and cells were grown for 24 h.
Images were obtained from the same fields immediately after scratching (t0) and after six and 24 h
using a Leica DMIL microscope and were analyzed using ImageJ software by manually selecting the
wound region and recording the total area.
The experiments were conducted in duplicate, in three independent experiments. Untreated
scratched cells represented the control.
The percentage of wound closure was calculated using the following formula:
% Wound closure = [(Wound area t0 −Wound area t)/Wound area t0] × 100
where t is the time in hours.
Results was then normalized to the control group.
3.9. HaCaT Cell Proliferation Assay
Cell proliferation was assessed by means of sulforhodamine B (SRB, Sigma-Aldrich) assay,
as previously reported [21]. Briefly, HaCaT cells (1 × 104) were seeded into 96-well plates and allowed
to grow for 24 h. Cells were then treated with increasing concentrations of HM and incubated for 6,
24, 48 and 72 h. After the incubation time, medium were replaced and cells were fixed by adding
trichloroacetic acid to a final concentration of 10% (v/v) for one h at 4 ◦C. Cells were washed, and 0.4%
SRB solution was added to each well and incubated for 30 min at rt. Cells were then washed with 1%
(v/v) acetic acid, and SRB was solubilized with 10 mM of Tris (Sigma-Aldrich, pH = 10.5). Absorbance
was recorded at 540 nm using a MP96 spectrophotometer (Safas, Monaco). Treatments were performed
in sextuplicate in three independent experiments, and cell proliferation was calculated by normalizing
the absorbance of the test wells to the untreated control.
3.10. TGF-β Production and MMP-9 Release
After the scratch wound-healing assay, supernatants were collected, centrifuged (4 ◦C, 15,000 g ×
15 min), and frozen at −80 ◦C for MMP-9 dosage. Adherent cells were washed twice in PBS and lysed
for TGF-β dosage. Protein content of sample lysate was determined by Bradford protein assay [30].
TGF-β production and MMP-9 release were assessed by non-competitive “sandwich” ELISA kit
(Biolegend e-Bioscience DX Diagnostic, Monza, Italy), according to the provider datasheet. Absorbance
was recorded at 450 nm using a SAFAS MP96 spectrophotometer.
3.11. Inhibition of Nitric Oxide (NO) Production in Lipopolysaccharide (LPS)-Stimulated RAW 264.7 Cells
Inhibition of NO production was assessed as previously reported [31]. Briefly, RAW 264.7 cells
were seeded in 24 well plates, at a density of 2 × 105 cells/well and incubated overnight in complete
medium. The following day, medium was replaced with fresh DMEM and then cells were treated for
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24 h with LPS (1 µg/mL) and different concentrations of extracts (ranging from 0.1 to 10 µg/mL). DMSO
was used as a vehicle control. After 24 h, 100 µL of cell culture supernatant were incubated with
100 µL of Griess reagent (Sigma-Aldrich) at room temperature for 10 min in a 96-well plate and then,
to quantify nitrites, stable products of NO, the absorbance was measured at 550 nm using a microplate
reader (Synergy H1 microplate reader, BioTek, Winooski, USA). The absence of treatment-induced
cytotoxic effects on RAW 264.7 cells was verified monitoring cell viability by MTT assay, as previously
described [32]. LPS-stimulated RAW 264.7 cells were treated with increasing doses (0.1 to 10 µg/mL) of
the extracts (as indicated) or DMSO (Ctrl). Data were expressed as percentage of nitrite production
versus control (DMSO-treated cells).
3.12. Statistical Analysis
The statistical differences were determined by the analysis of the variance (ANOVA). Shapiro-Wilk
normality test was used to check the normality distribution of variables. Values are expressed in the
range of +/− standard deviation and p < 0.05 was considered statistically significant. Graphs and
calculations were performed using Graphpad Prism.
4. Conclusions
Wine-making process furnishes large amounts of pomace that could be exploited for their
health-promoting properties. The white berry pomaces are still scarcely investigated, furnishing the
opportunity to develop new valuable pharmaceutical ingredients. In this work, we compared the GS
extracts of Mantonico and Pecorello, and the differences of fatty acids profiles and other phytochemicals,
such as carotenoids and polyphenols. In vitro, the linoleic acid-rich extract HM resulted a useful
wound healing agent, while HP, rich in carotenoids, showed the most suitable anti-inflammatory
activity, opening the way for translational or technological investigations of agro-food by-products.
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Figure S13. HaCaT cell viability assay.
Author Contributions: Conceptualization, G.C., S.M., F.A., and P.G.; methodology, P.G., L.F., S.M.; software,
G.G., F.S.; validation, F.A., A.R.C., M.E.D.C.; investigation, G.C., S.M., L.F., P.G., G.G.; data curation, F.A., G.Cr.;
writing—original draft preparation, G.C., P.G., L.F., F.A.; writing—review and editing, A.R.C., S.M.; funding
acquisition, L.F. All authors have read and agreed to the published version of the manuscript.
Funding: L.F. is funded by PAC CALABRIA 2014-2020-Asse Prioritario 12, Azione B 10.5.12 CUP: H28D19000040006.
Acknowledgments: We thank Marco Biagi, Department of Physics, Earth and Environmental Sciences, Unversity
of Siena, for its technical support.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Restuccia, D.; Giorgi, G.; Gianfranco Spizzirri, U.; Sciubba, F.; Capuani, G.; Rago, V.; Carullo, G.; Aiello, F.
Autochthonous white grape pomaces as bioactive source for functional jams. Int. J. Food Sci. Technol. 2019,
54, 1313–1320. [CrossRef]
2. Rubio, M.; Alvarez-Ortí, M.; Alvarruiz, A.; Fernández, E.; Pardo, J.E. Characterization of oil obtained from
grape seeds collected during berry development. J. Agric. Food Chem. 2009, 57, 2812–2815. [CrossRef]
3. Carullo, G.; Governa, P.; Spizzirri, U.G.; Biagi, M.; Sciubba, F.; Giorgi, G.; Loizzo, M.R.; Di Cocco, M.E.;
Aiello, F.; Restuccia, D. Sangiovese cv pomace seeds extract-fortified kefir exerts anti-inflammatory activity
in an in vitro model of intestinal epithelium using caco-2 cells. Antioxidants 2020, 9, 54. [CrossRef] [PubMed]
4. Sotiropoulou, E.I.; Varelas, V.; Liouni, M.; Nerantzis, E.T. Grape seed oil: From a winery waste to a value
added cosmetic product-a review. Edible Med. Non-Med. Plants 2012, 2, 867–878.
Pharmaceuticals 2020, 13, 97 11 of 12
5. Carullo, G.; Durante, M.; Sciubba, F.; Restuccia, D.; Spizzirri, U.G.; Ahmed, A.; Di Cocco, M.E.; Saponara, S.;
Aiello, F.; Fusi, F. Vasoactivity of Mantonico and Pecorello grape pomaces on rat aorta rings: An insight into
nutraceutical development. J. Funct. Foods 2019, 57, 328–334. [CrossRef]
6. García-Lomillo, J.; González-SanJosé, M.L.; Del Pino-García, R.; Rivero-Pérez, M.D.; Muñiz-Rodríguez, P.
Antioxidant and antimicrobial properties of wine byproducts and their potential uses in the food industry.
J. Agric. Food Chem. 2014, 62, 12595–12602. [CrossRef]
7. Zhang, X.; Mao, A.; Xiao, W.; Zhang, P.; Han, X.; Zhou, T.; Chen, Y.; Jin, J.; Ma, X. Morin induces
endothelium-dependent relaxation by activating TRPV4 channels in rat mesenteric arteries. Eur. J. Pharmacol.
2019, 859, 172561. [CrossRef]
8. Garavaglia, J.; Markoski, M.M.; Oliveira, A.; Marcadenti, A. Grape seed oil compounds: Biological and
chemical actions for health. Nutr. Metab. Insights 2016, 9, 59–64. [CrossRef]
9. Unusan, N. Proanthocyanidins in grape seeds: An updated review of their health benefits and potential uses
in the food industry. J. Funct. Foods 2020, 67, 103861. [CrossRef]
10. Lucarini, M.; Durazzo, A.; Romani, A.; Campo, M.; Lombardi-Boccia, G.; Cecchini, F. Bio-based compounds
from grape seeds: A biorefinery approach. Molecules 2018, 23, 1888. [CrossRef]
11. Lucarini, M.; Durazzo, A.; Kiefer, J.; Santini, A.; Lombardi-Boccia, G.; Souto, E.B.; Romani, A.; Lampe, A.;
Nicoli, S.F.; Gabrielli, P.; et al. Grape seeds: Chromatographic profile of fatty acids and phenolic compounds
and qualitative analysis by FTIR-ATR spectroscopy. Foods 2020, 9, 10. [CrossRef] [PubMed]
12. Governa, P.; Carullo, G.; Biagi, M.; Rago, V.; Aiello, F. Evaluation of the in vitro wound-healing activity of
calabrian honeys. Antioxidants 2019, 8, 36. [CrossRef] [PubMed]
13. Hemmati, A.A.; Aghel, N.; Rashidi, I.; Gholampur-Aghdami, A. Topical grape (Vitis vinifera) seed extract
promotes repair of full thickness wound in rabbit. Int. Wound J. 2011, 8, 514–520. [CrossRef] [PubMed]
14. Khanna, S.; Venojarvi, M.; Roy, S.; Sharma, N.; Trikha, P.; Bagchi, D.; Bagchi, M.; Sen, C.K. Dermal wound
healing properties of redox-active grape seed proanthocyanidins. Free Radic. Biol. Med. 2002, 33, 1089–1096.
[CrossRef]
15. Hemmati, A.A.; Foroozan, M.; Houshmand, G.; Moosavi, Z.B.; Bahadoram, M.; Maram, N.S. The topical
effect of grape seed extract 2% cream on surgery wound healing. Glob. J. Health Sci. 2015, 7, 52–58. [CrossRef]
16. Ma, H.; Zhou, Q.; Chang, J.; Wu, C. Grape seed-inspired smart hydrogel scaffolds for melanoma therapy and
wound healing. ACS Nano 2019, 13, 4302–4311. [CrossRef]
17. Moalla Rekik, D.; Ben Khedir, S.; Ksouda Moalla, K.; Kammoun, N.G.; Rebai, T.; Sahnoun, Z. Evaluation of
wound healing properties of grape seed, sesame, and fenugreek oils. Evid. Based. Complement Alternat. Med.
2016, 2016, 7965689. [CrossRef]
18. McDaniel, J.C.; Belury, M.; Ahijevych, K.; Blakely, W. Omega-3 fatty acids effect on wound healing.
Wound Repair Regen. 2008, 16, 337–345. [CrossRef]
19. Silva, J.R.; Burger, B.; Kühl, C.M.C.; Candreva, T.; dos Anjos, M.B.P.; Rodrigues, H.G. Wound healing and
omega-6 fatty acids: From inflammation to repair. Mediat. Inflamm. 2018, 2018, 2503950. [CrossRef]
20. Pereira, L.M.; Hatanaka, E.; Martins, E.F.; Oliveira, F.; Liberti, E.A.; Farsky, S.H.; Curi, R.; Pithon-Curi, T.C.
Effect of oleic and linoleic acids on the inflammatory phase of wound healing in rats. Cell Biochem. Funct.
2008, 26, 197–204. [CrossRef]
21. Carullo, G.; Governa, P.; Leo, A.; Gallelli, L.; Citraro, R.; Cione, E.; Caroleo, M.C.; Biagi, M.; Aiello, F.;
Manetti, F. Quercetin-3-Oleate contributes to skin wound healing targeting FFA1/GPR40. ChemistrySelect
2019, 4, 8429–8433. [CrossRef]
22. Carullo, G.; Perri, M.; Manetti, F.; Aiello, F.; Caroleo, M.C.; Cione, E. Quercetin-3-oleoyl derivatives as new
GPR40 agonists: Molecular docking studies and functional evaluation. Bioorganic Med. Chem. Lett. 2019, 29,
1761–1764. [CrossRef] [PubMed]
23. Chen, D.; Hao, H.; Fu, X.; Han, W. Insight into reepithelialization: How do mesenchymal stem cells perform?
Stem Cells Int. 2016, 2016, 6120173. [CrossRef] [PubMed]
24. Mazgaeen, L.; Gurung, P. Recent advances in lipopolysaccharide recognition systems. Int. J. Mol. Sci. 2020,
21, 379. [CrossRef]
25. Kaulmann, A.; Bohn, T. Carotenoids, inflammation, and oxidative stress–implications of cellular signaling
pathways and relation to chronic disease prevention. Nutr. Res. 2014, 34, 907–929. [CrossRef]
26. Kawata, A.; Murakami, Y.; Suzuki, S.; Fujisawa, S. Anti-inflammatory activity of β-carotene, lycopene and
Tri-n-butylborane, a scavenger of reactive oxygen species. In Vivo 2018, 32, 255–264.
Pharmaceuticals 2020, 13, 97 12 of 12
27. Perri, F.; Frattaruolo, L.; Haworth, I.; Brindisi, M.; El-magboub, A.; Ferrario, A.; Gomer, C.; Aiello, F.;
Adams, J.D. Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2
levels by decreasing COX2 activity and expression. Heliyon 2019, 5, e01366. [CrossRef]
28. Borgonetti, V.; Governa, P.; Biagi, M.; Dalia, P.; Corsi, L. Rhodiola rosea L. modulates inflammatory processes
in a CRH-activated BV2 cell model. Phytomedicine 2020, 68, 153143. [CrossRef]
29. Chiocchio, I.; Poli, F.; Governa, P.; Biagi, M.; Lianza, M. Wound healing and in vitro antiradical activity of five
Sedum species grown within two sites of community importance in Emilia-Romagna (Italy). Plant Biosyst.-An
Int. J. Deal. All Asp. Plant Biol. 2019, 153, 610–615. [CrossRef]
30. He, F. Bradford protein assay. Bio-protocol 2011, 1, e45. [CrossRef]
31. Mazzotta, S.; Frattaruolo, L.; Brindisi, M.; Ulivieri, C.; Vanni, F.; Brizzi, A.; Carullo, G.; Cappello, A.R.;
Aiello, F. 3-Amino-alkylated indoles: Unexplored green products acting as anti-inflammatory agents.
Future Med. Chem. 2020, 12, 5–17. [CrossRef] [PubMed]
32. Frattaruolo, L.; Carullo, G.; Brindisi, M.; Mazzotta, S.; Bellissimo, L.; Rago, V.; Curcio, R.; Dolce, V.; Aiello, F.;
Cappello, A.R. Antioxidant and anti-inflammatory activities of flavanones from Glycyrrhiza glabra L. (licorice)
leaf phytocomplexes: Identification of licoflavanone as a modulator of NF-kB/MAPK pathway. Antioxidants
2019, 8, 186. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
